Barbados

Barbados does not operate a national population-level dementia screening program. Case finding occurs opportunistically through clinical encounters in primary care, hospital settings, or via family-initiated consultations prompted by functional decline. Dementia awareness is referenced in the National Policy on Ageing, but primarily as part of broader healthy ageing and elder-care frameworks rather than as a standalone early detection strategy. Both Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA) are utilized in clinical settings and research within Barbados for screening dementia and mild cognitive impairment (MCI). Barbados participated in the SABE (Health, Well-being, and Aging) study, which used the MMSE to analyze how factors like education and occupation affect cognitive decline in older adults. Educational attainment is known to influence performance on commonly used cognitive screening tools such as the MMSE and MoCA. Consequently, clinicians interpreting these instruments may consider educational background when evaluating results, particularly in populations with diverse educational experiences. Although no Barbados-specific guidance on education-adjusted cutoffs could be identified, international evidence suggests that reliance on a single universal cutoff may reduce diagnostic accuracy in heterogeneous populations.

Structural neuroimaging, primarily computed tomography (CT) and, where clinically indicated, magnetic resonance imaging (MRI), is available in Barbados through hospital-based radiology services, notably at the Queen Elizabeth Hospital, the country’s main public tertiary referral center. Imaging is used mainly to support differential diagnosis by excluding stroke, tumors, hydrocephalus, or other structural causes of cognitive impairment. Requests for suspected dementia are initiated at the specialist level and processed through general radiology queues, rather than dementia-specific pathways. In the absence of acute neurological symptoms, neuroimaging for suspected dementia is generally undertaken as part of the routine diagnostic work-up of cognitive impairment rather than as an emergency investigation. No publicly available evidence could be identified indicating the existence of a dedicated expedited dementia-imaging pathway in Barbados.

Genetic testing for dementia risk, including apolipoprotein E (APOE) genotyping, does not form part of standard public diagnostic pathways in Barbados. There is no indication that predictive or confirmatory genetic testing is routinely offered, funded, or ethically framed within the public system for dementia care. Genetic services, where available, are more likely confined to research contexts or private arrangements rather than integrated clinical practice. This reinforces a model in which diagnosis is phenomenological and clinical, rather than predictive or precision-based, aligning with the country’s universal but non-specialized health system orientation.

There is no evidence in national policy documents, clinical guidelines, or public health communications that cerebrospinal fluid (CSF) biomarkers (such as amyloid-β or tau) or blood-based biomarkers are incorporated into routine public dementia diagnostics in Barbados.

Barbados does not operate a formal, nationally designated memory clinic network, and there is no evidence in public policy documents of dementia-specific outpatient units structured. Instead, dementia treatment and follow-up are embedded within general healthcare services, with management distributed across primary care, hospital-based specialist consultations (neurology, psychiatry, geriatrics where available), and community services. Primary care remains the backbone of ongoing management, particularly for stable patients and those in early or moderate stages, with referrals back to specialists occurring episodically rather than through a continuous specialist-led model. This results in a decentralized care structure, adequate for basic follow-up but limited in multidisciplinary coordination (neuropsychology, occupational therapy, social work) specific to dementia.
Private in-home care services play an important role, especially for moderate to advanced dementia. These services typically focus on assistance with activities of daily living, supervision, medication adherence, and short-term respite for family carers. While they help compensate for limited public long-term care infrastructure, access is largely determined by household financial capacity. Civil-society organizations, most notably the Barbados Alzheimer’s Association, provide education, awareness-raising, career guidance, and psychosocial support. Their role is complementary rather than substitutive, filling gaps in counseling, stigma reduction, and caregiver navigation rather than delivering clinical care.

Families, often older spouses or adult children, serve as the primary providers of long-term dementia care, frequently without formal respite services or financial compensation. This can lead to physical, emotional, and economic strain, particularly in prolonged disease trajectories. The National Policy on Ageing explicitly recognizes the need for career education and training as part of broader support for older people. Policy commitments include capacity-building for informal carers and service providers, promotion of carer skills, and improved awareness of dementia-related needs. In practice, however, implementation remains uneven and largely dependent on non-governmental organisation (NGO) initiatives and informal networks rather than systematic service provision. Overall, treatment and care for dementia in Barbados are characterized by universal access to basic medical services, limited specialization, strong reliance on families, and a growing but largely privatized care economy, with NGOs playing a crucial bridging role between policy intent and lived experience.

Barbados has articulated its approach to ageing and cognitive health primarily through cross-cutting policy frameworks rather than a dedicated dementia plan. The National Policy on Ageing (originally adopted in 2012, with updated strategic documents extending to 2028) explicitly references dementia awareness, carer support, and training within broader objectives on healthy ageing, social protection, and community-based care. Dementia is framed as a growing public health and social issue linked to population ageing, but addressed indirectly rather than through a condition-specific pathway. In parallel, Barbados implemented the National Strategic Plan for the Prevention and Control of Non-Communicable Diseases (2020–2025), which emphasizes strengthening primary care, early diagnosis, and long-term management of chronic conditions. While not dementia-specific, the NCD plan is relevant insofar as it prioritizes disability reduction, continuity of care, and integration of health services for older adults, domains directly affected by dementia prevalence.

Recent policy discourse and planning documents signal incremental momentum toward better dementia preparedness, even in the absence of a standalone strategy. National frameworks increasingly emphasize awareness-building around ageing-related conditions, structured education and training for carers and frontline providers, strengthening of home-based care and social-support services, and gradual improvement of registries and data systems related to older populations. There is also a growing policy focus on integrated community support networks, reflecting recognition that dementia care extends beyond clinical settings. At the regional level, World Health Organization (WHO)/Pan American Health Organization (PAHO)-led Caribbean dialogues and ageing-health initiatives consistently call for improved dementia readiness, workforce training, and health-system responsiveness across small island states, including Barbados. These regional agendas reinforce national discussions and provide a policy reference point, even where domestic implementation remains partial.

Looking ahead, strategic updates linked to the post-2025 NCD agenda and the ongoing implementation of the National Policy on Ageing are expected to further emphasize community-based care, ageing-in-place, and support for informal carers. While no formal announcement of a national dementia plan has been identified, dementia is increasingly positioned as a priority condition within healthy-ageing and social-care reform discussions, suggesting a likely continuation of incremental integration rather than abrupt policy separation. Future strategy development is therefore expected to focus on strengthening primary-care capacity, improving coordination between health and social services, and enhancing data collection on older adults, creating the structural preconditions for more explicit dementia policy should political prioritization increase.